Comparison of the immunogenicity and safety of Cervarix and Gardasil human papillomavirus (HPV) cervical cancer vaccines in healthy women aged 18-45 years. [electronic resource]
Producer: 20101215Description: 705-19 p. digitalISSN:- 1554-8619
- Adolescent
- Adult
- Antibodies, Neutralizing -- blood
- Antibodies, Viral -- blood
- Cancer Vaccines -- adverse effects
- Female
- Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
- Humans
- Middle Aged
- Neutralization Tests
- Papillomaviridae -- isolation & purification
- Papillomavirus Infections -- prevention & control
- Papillomavirus Vaccines -- adverse effects
- Young Adult
No physical items for this record
Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.